Nanoparticles loaded with natural medicines for the treatment of Alzheimer's disease
- PMID: 37877008
- PMCID: PMC10590901
- DOI: 10.3389/fnins.2023.1112435
Nanoparticles loaded with natural medicines for the treatment of Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease that disrupts cognitive function and severely affects the quality of life. Existing drugs only improve cognitive function and provide temporary relief of symptoms but do not stop or delay disease progression. Recently, natural medicines, especially Chinese herbal medicines, have gained attention in the treatment of AD due to their antioxidant, anti-inflammatory, and neuroprotective effects. However, conventional oral dosage forms lack brain specificity and have side effects that lead to poor patient compliance. Utilizing nanomedicine is a promising approach to improve brain specificity, bioavailability, and patient compliance. This review evaluates recent advances in the treatment of AD with nanoparticles containing various natural medicines. This review highlights that nanoparticles containing natural medicines are a promising strategy for the treatment of AD. It is believed that this technology can be translated into the clinic, thereby providing opportunities for AD patients to participate in social activities.
Keywords: Alzheimer’s disease; Chinese herbal medicines; blood–brain barrier; nanoparticles; natural medicines.
Copyright © 2023 Liu, Ruan, Li and Fu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.J Control Release. 2020 Sep 10;325:25-37. doi: 10.1016/j.jconrel.2020.05.044. Epub 2020 May 28. J Control Release. 2020. PMID: 32473177 Review.
-
Potential therapeutic effects of naringin loaded PLGA nanoparticles for the management of Alzheimer's disease: In vitro, ex vivo and in vivo investigation.Heliyon. 2023 Aug 22;9(9):e19374. doi: 10.1016/j.heliyon.2023.e19374. eCollection 2023 Sep. Heliyon. 2023. Retraction in: Heliyon. 2025 Mar 12;11(6):e43149. doi: 10.1016/j.heliyon.2025.e43149. PMID: 37662728 Free PMC article. Retracted.
-
Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.Pharmaceutics. 2022 Apr 11;14(4):835. doi: 10.3390/pharmaceutics14040835. Pharmaceutics. 2022. PMID: 35456671 Free PMC article. Review.
-
Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art.Biomedicines. 2023 Jun 18;11(6):1752. doi: 10.3390/biomedicines11061752. Biomedicines. 2023. PMID: 37371847 Free PMC article. Review.
-
Recent progress of nanomedicine in the treatment of Alzheimer's disease.Front Cell Dev Biol. 2023 Jun 29;11:1228679. doi: 10.3389/fcell.2023.1228679. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37457297 Free PMC article. Review.
Cited by
-
Materials, Syntheses and Biomedical Applications of Nano-Quercetin Formulations: A Comprehensive Literature Review.Int J Nanomedicine. 2025 Jul 5;20:8729-8764. doi: 10.2147/IJN.S517079. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40635717 Free PMC article. Review.
-
Engineered nanoparticles for the treatment of Alzheimer's disease.Front Pharmacol. 2025 Apr 3;16:1510798. doi: 10.3389/fphar.2025.1510798. eCollection 2025. Front Pharmacol. 2025. PMID: 40248097 Free PMC article. Review.
-
Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease.Curr Pharm Des. 2025;31(8):598-618. doi: 10.2174/0113816128344571241018154506. Curr Pharm Des. 2025. PMID: 39492772 Review.
References
-
- Abdulmalek S., Nasef M., Awad D., Balbaa M. (2021). Protective effect of natural antioxidant, curcumin nanoparticles, and zinc oxide nanoparticles against type 2 diabetes-promoted hippocampal neurotoxicity in rats. Pharmaceutics 13:1937. doi: 10.3390/pharmaceutics13111937, PMID: - DOI - PMC - PubMed
-
- Abozaid O., Sallam M. W., el-Sonbaty S., Aziza S., Emad B., Ahmed E. S. A. (2022). Resveratrol-selenium nanoparticles alleviate Neuroinflammation and neurotoxicity in a rat model of Alzheimer’s disease by regulating Sirt1/miRNA-134/GSK3β expression. Biol. Trace Elem. Res. 200, 5104–5114. doi: 10.1007/s12011-021-03073-7, PMID: - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources